Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery MEQUON, Wis., June 30, 2026 /PRNewswire/ -- ...

The content in this section is supplied by PR Newswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. Nucala is the only approved ...

Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a wearable transdermal delivery platform that uses a pulsed magnetic field to ...

Glaukos has completed patient enrolment in its Phase II clinical trial evaluating GLK-321 for the treatment of Demodex ...

Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Nutriband ( (NTRB)) just unveiled an update. On June 1, 2026, Nutriband entered into an amended ...

The FDA approved an update to the labeled strength of Twirla, a weekly contraceptive patch, its manufacturer announced.The ...

ETHealthworld.com brings latest zydus lifesciences news, views and updates from all top sources for the Indian Health industry.

The latest study released on the Global Transdermal Drug Delivery System Market by HTF MI evaluates market size, trend, and forecast to 2033. The Transdermal Drug Delivery System market study covers ...

Abstract: The development of transdermal drug delivery systems in medicine is moving towards increasing their precision, minimal invasiveness, and safety for long-term topical use to monitor and ...

Presentation to highlight preclinical pharmacokinetic and safety data supporting once-daily usage of Corsair’s TRX-248 Transdermal System, now in a Phase 1 clinical study NEWARK, Calif.--(BUSINESS ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches. Alvogen announced on Jan. 31, 2025 that it is voluntarily ...